Anna Lia Molinari

1.9k total citations
31 papers, 703 citations indexed

About

Anna Lia Molinari is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Anna Lia Molinari has authored 31 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 6 papers in Oncology. Recurrent topics in Anna Lia Molinari's work include Lymphoma Diagnosis and Treatment (11 papers), Neurological disorders and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Anna Lia Molinari is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Neurological disorders and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Anna Lia Molinari collaborates with scholars based in Italy, United States and Switzerland. Anna Lia Molinari's co-authors include David Charles, Peter Hedera, Peter E. Konrad, Fenna T. Phibbs, Thomas L. Davis, Kevin R. Cannard, Alfonso Zaccaria, Chandler E. Gill, Mallory L. Hacker and Amanda Currie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Anna Lia Molinari

30 papers receiving 688 citations

Peers

Anna Lia Molinari
Johnny P.A. Samijn Netherlands
J. Franques France
Sindhu Ramchandren United States
Ellen Lathi United States
Philip Kane United Kingdom
Madhura A. Tamhankar United States
Panagiotis Toulas Greece
Brian G. Mohney United States
Renata Simm Brazil
Bertrand Bourre France
Johnny P.A. Samijn Netherlands
Anna Lia Molinari
Citations per year, relative to Anna Lia Molinari Anna Lia Molinari (= 1×) peers Johnny P.A. Samijn

Countries citing papers authored by Anna Lia Molinari

Since Specialization
Citations

This map shows the geographic impact of Anna Lia Molinari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lia Molinari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lia Molinari more than expected).

Fields of papers citing papers by Anna Lia Molinari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lia Molinari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lia Molinari. The network helps show where Anna Lia Molinari may publish in the future.

Co-authorship network of co-authors of Anna Lia Molinari

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lia Molinari. A scholar is included among the top collaborators of Anna Lia Molinari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lia Molinari. Anna Lia Molinari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bannerji, Rajat, Sam Yuen, Tycel Phillips, et al.. (2021). POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL. Hematological Oncology. 39(S2). 3 indexed citations
2.
Merli, Francesco, Federica Cavallo, Flavia Salvi, et al.. (2019). Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. Journal of Geriatric Oncology. 11(1). 37–40. 15 indexed citations
3.
Turchan, Maxim, Chandler E. Gill, Amanda Currie, et al.. (2018). Inter-rater reliability of a novel spasticity diagnostic algorithm. 3(3). 5. 1 indexed citations
4.
Hacker, Mallory L., et al.. (2017). Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson’s Disease Is Not Associated with Increased Body Mass Index. Parkinson s Disease. 2017. 1–4. 7 indexed citations
5.
Ferrero, Simone, Davide Rossi, Alessio Bruscaggin, et al.. (2017). KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL. Hematological Oncology. 35(S2). 94–95. 2 indexed citations
6.
Hacker, Mallory L., Amanda Currie, Anna Lia Molinari, et al.. (2016). Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson’s Disease. Journal of Parkinson s Disease. 6(1). 125–131. 24 indexed citations
7.
Molinari, Anna Lia, et al.. (2016). SAT0570 Biologics and Biosimilars: Do Physicians Understand The Differences?. Annals of the Rheumatic Diseases. 75. 875–876. 1 indexed citations
8.
Tramontana, Michael G., Anna Lia Molinari, Peter E. Konrad, et al.. (2015). Neuropsychological Effects of Deep Brain Stimulation in Subjects with Early Stage Parkinson's Disease in a Randomized Clinical Trial. Journal of Parkinson s Disease. 5(1). 151–163. 24 indexed citations
9.
Camalier, Corrie R., Peter E. Konrad, Chandler E. Gill, et al.. (2014). Methods for Surgical Targeting of the STN in Early-Stage Parkinson’s Disease. Frontiers in Neurology. 5. 25–25. 16 indexed citations
10.
Charles, David, Peter E. Konrad, Joseph S. Neimat, et al.. (2014). Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism & Related Disorders. 20(7). 731–737. 95 indexed citations
11.
Charles, David, Christopher Tolleson, Thomas L. Davis, et al.. (2012). Pilot Study Assessing the Feasibility of Applying Bilateral Subthalamic Nucleus Deep Brain Stimulation in Very Early Stage Parkinson's Disease: Study Design and Rationale. Journal of Parkinson s Disease. 2(3). 215–223. 16 indexed citations
12.
Zaja, Francesco, Alfonso Zaccaria, M. Lenoci, et al.. (2006). CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 47(10). 2174–2180. 40 indexed citations
13.
Zinzani, Pier Luigi, Monica Tani, Lapo Alinari, et al.. (2005). Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. Leukemia & lymphoma. 46(10). 1449–1454. 7 indexed citations
14.
Zinzani, Pier Luigi, Alessandro Pulsoni, Patrizia Gentilini, et al.. (2004). Effectiveness of Fludarabine, Idarubicin and Cyclophosphamide (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 45(9). 1815–1819. 5 indexed citations
15.
Zaja, Francesco, Nicola Vianelli, Alessandra Sperotto, et al.. (2003). B-cell compartment as the selective target for the treatment of immune thrombocytopenias.. PubMed. 88(5). 538–46. 76 indexed citations
16.
Poletti, Venerino, Marzia Salvucci, Anna Lia Molinari, et al.. (2000). The lung as a target organ in patients with hematologic disorders.. PubMed. 85(8). 855–64. 18 indexed citations
17.
Visani, Giuseppe, Patrizia Tosi, Emanuela Ottaviani, et al.. (1996). All‐trans retinoic acid and in vitro cytokine production by acute promyelocytic eukemia cells. European Journal Of Haematology. 57(4). 301–306. 12 indexed citations
18.
Zinzani, Pier Luigi, Alfonso Zaccaria, Giuseppe Visani, et al.. (1996). Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low‐grade non‐Hodgkin's lymphoma. European Journal Of Haematology. 57(5). 335–340. 21 indexed citations
19.
Cruciani, Giorgio, A. Tienghi, Anna Lia Molinari, et al.. (1987). Cyclophosphamide, Methotrexate, 5-Fluorouracil, Alternating with Adriamycin and Mitomycin C in Metastatic Breast Cancer: A Pilot Study. Tumori Journal. 73(3). 303–307. 2 indexed citations
20.
Molinari, Anna Lia, et al.. (1987). Applicability of Local Hyperthermia as Adjuvant to Systemic Chemotherapy. Tumori Journal. 73(6). 629–633. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johnny P.A. Samijn Breakdown of academic impact, for papers by J. Franques Breakdown of academic impact, for papers by Sindhu Ramchandren Breakdown of academic impact, for papers by Ellen Lathi Breakdown of academic impact, for papers by Philip Kane Breakdown of academic impact, for papers by Madhura A. Tamhankar Breakdown of academic impact, for papers by Panagiotis Toulas Breakdown of academic impact, for papers by Brian G. Mohney Breakdown of academic impact, for papers by Renata Simm Breakdown of academic impact, for papers by Bertrand Bourre
Rankless by CCL
2026